Global Key SolutionsGKS
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. NuVasive, Incorporated
483
•NuVasive, Incorporated•December 21, 2020

FDA 483 - NuVasive, Incorporated - December 21, 2020

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents
Record Details

This FDA Form 483 report for NuVasive, Incorporated indicates that no inspectional observations were noted during the inspection. The report suggests that the firm was found to be in compliance with regulatory requirements at the time of the inspection.

Company
NuVasive, Incorporated
Inspection Date
December 21, 2020
Product Type
Device
Office
Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)
Person
  • Jennifer Houck
Open in Dashboard

ID · aaa48c6c-f44f-4226-b6ba-4703900c49f1

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
[email protected]
Quick Links
KeyPedia™ Lite
Legal & Ethics
©2026, Global Key Solutions All rights reserved.